Cargando…
BETs inhibition attenuates oxidative stress and preserves muscle integrity in Duchenne muscular dystrophy
Duchenne muscular dystrophy (DMD) affects 1 in 3500 live male births. To date, there is no effective cure for DMD, and the identification of novel molecular targets involved in disease progression is important to design more effective treatments and therapies to alleviate DMD symptoms. Here, we show...
Autores principales: | Segatto, Marco, Szokoll, Roberta, Fittipaldi, Raffaella, Bottino, Cinzia, Nevi, Lorenzo, Mamchaoui, Kamel, Filippakopoulos, Panagis, Caretti, Giuseppina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7705749/ https://www.ncbi.nlm.nih.gov/pubmed/33257646 http://dx.doi.org/10.1038/s41467-020-19839-x |
Ejemplares similares
-
Nitric Oxide (NO) and Duchenne Muscular Dystrophy: NO Way to Go?
por: Timpani, Cara A., et al.
Publicado: (2020) -
Adenylosuccinic acid therapy ameliorates murine Duchenne Muscular Dystrophy
por: Timpani, Cara A., et al.
Publicado: (2020) -
Targeting Epigenetic Regulators with HDAC and BET Inhibitors to Modulate Muscle Wasting
por: Nevi, Lorenzo, et al.
Publicado: (2023) -
Short (16-mer) locked nucleic acid splice-switching oligonucleotides restore dystrophin production in Duchenne Muscular Dystrophy myotubes
por: Pires, Vanessa Borges, et al.
Publicado: (2017) -
Survival in Duchenne muscular dystrophy
por: RALL, SUSANNE, et al.
Publicado: (2012)